PPA
OYST

Parametric Portfolio Associates’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Parametric Portfolio Associates’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,778
Closed -$282K – 3725
2021
Q3 		$282K Buy
+23,778
New +$346K ﹤0.01% 3328

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Parametric Portfolio Associates's OYST Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2021, closing a stake of 23,778 shares — an estimated $282K sold.

Parametric Portfolio Associates first reported a position in OYST in Q3 2021 and held it in 1 quarter. The position peaked at $282K in Q3 2021. 80 funds tracked by Wall St. Rank hold OYST as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 23,778 Oyster Point Pharma, Inc. Common Stock shares in Q4 2021, an estimated $282K.
  • Parametric Portfolio Associates first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's Oyster Point Pharma, Inc. Common Stock position peaked at $282K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.